---
title: Design, Rationale and Initial Findings From HERA-FIB on 10â€‰222 Patients With
  Atrial Fibrillation Presenting to an Emergency Department Over An 11-Year Period
date: '2024-04-19'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38639359/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240419180738&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'CONCLUSIONS: HERA-FIB is one of the largest real-world single-center
  retrospective registries on patients with AF, which captures the era of transition
  from vitamin K antagonists to non-vitamin K oral anticoagulation regimens in clinical
  practice and offers the possibility to investigate patient populations usually underrepresented
  or excluded in current available randomized controlled trials and ...'
disable_comments: true
---
CONCLUSIONS: HERA-FIB is one of the largest real-world single-center retrospective registries on patients with AF, which captures the era of transition from vitamin K antagonists to non-vitamin K oral anticoagulation regimens in clinical practice and offers the possibility to investigate patient populations usually underrepresented or excluded in current available randomized controlled trials and ...